请输入您要查询的百科知识:

 

词条 Zonampanel
释义

  1. References

{{Drugbox
| IUPAC_name = [7-(1H-Imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalinyl]acetic acid
| image = Zonampanel.svg
| alt = Skeletal formula
| width = 200
| image2 = Zonampanel molecule spacefill.png
| alt2 = Space-filling model of zonampanel
| CAS_number = 210245-80-0
| ATC_prefix = None
| ATC_suffix =
| PubChem = 148200
| DrugBank =
| ChemSpiderID = 130649
| C=13 | H=9 | N=5 | O=6
| molecular_weight = 331.241 g/mol
| smiles = c1cn(cn1)c2cc3c(cc2[N+](=O)[O-])[nH]c(=O)c(=O)n3CC(=O)O
| StdInChI = 1S/C13H9N5O6/c19-11(20)5-17-8-4-9(16-2-1-14-6-16)10(18(23)24)3-7(8)15-12(21)13(17)22/h1-4,6H,5H2,(H,15,21)(H,19,20)
| StdInChIKey = SPXYHZRWPRQLNS-UHFFFAOYSA-N
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category=
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =
}}Zonampanel (INN, code name YM872) is a quinoxalinedione derivative drug and competitive antagonist of the AMPA receptor which was being investigated by Yamanouchi/Astellas Pharma as a neuroprotective drug for the treatment of ischemic stroke but never completed clinical trials.[1][2][3][4] In clinical trials, zonampanel produced severe side effects including hallucinations, agitation, and catatonia in patients, resulting in early termination of the trials.[5]

References

1. ^{{cite book|author=Kewal K. Jain|title=The Handbook of Neuroprotection|url=https://books.google.com/books?id=PGZ3Qqvjmo0C&pg=PA154|date=14 February 2011|publisher=Springer Science & Business Media|isbn=978-1-61779-049-2|pages=154–}}
2. ^{{cite book|author=Arunabha Ray, Kavita Gulati|title=Current Trends in Pharmacology|url=https://books.google.com/books?id=uB2vWIQBbxoC&pg=PA321|date=1 January 2007|publisher=I. K. International Pvt Ltd|isbn=978-81-88237-77-7|pages=321–}}
3. ^{{cite book|author=Stephen Waxman|title=Multiple Sclerosis As A Neuronal Disease|url=https://books.google.com/books?id=Eeqy733NZSEC&pg=PA245|date=27 May 2005|publisher=Academic Press|isbn=978-0-08-048941-4|pages=245–}}
4. ^{{cite book|author1=Santokh Gill|author2=Olga Pulido|title=Glutamate Receptors in Peripheral Tissue: Excitatory Transmission Outside the CNS|url=https://books.google.com/books?id=wcjiZ58mypIC&pg=PA37|date=31 January 2007|publisher=Springer Science & Business Media|isbn=978-0-306-48644-9|pages=37–}}
5. ^{{cite book|author=Akhlaq A. Farooqui|title=Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases|url=https://books.google.com/books?id=q_G5aon0WbAC&pg=PA73|date=2 September 2010|publisher=Springer Science & Business Media|isbn=978-1-4419-6652-0|pages=73–}}
{{Ionotropic glutamate receptor modulators}}{{nervous-system-drug-stub}}

7 : AMPA receptor antagonists|Imidazoles|Neuroprotective agents|Nitro compounds|Quinoxalines|Astellas Pharma|Acetic acids

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/21 17:40:58